
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
ProShares
ETF
Equity
- years
8 holdings
$15.45
Price-1.77%
-$0.28
$2.290m
Small
$13.369k
Avg Volume$3.353m
$15.02
NAV0.95%
Expense Ratio5.63%
Yield$0.87
Dividend